Difference between revisions of "Graft versus host disease"
Jump to navigation
Jump to search
m (moved Graft versus host to Graft versus host disease (GVHD)) |
|||
Line 23: | Line 23: | ||
===Glucksberg grade=== | ===Glucksberg grade=== | ||
− | {| border="1" | + | {| border="1" style="text-align:center;" |
− | !Overall grade | + | !align="left" | Overall grade |
!I | !I | ||
!II | !II | ||
Line 30: | Line 30: | ||
!IV | !IV | ||
|- | |- | ||
− | |Skin | + | |align="left" | Skin |
|1-2 | |1-2 | ||
|1-3 | |1-3 | ||
Line 36: | Line 36: | ||
|2-4 | |2-4 | ||
|- | |- | ||
− | |GI | + | |align="left" | GI |
|0 | |0 | ||
|1 | |1 | ||
Line 42: | Line 42: | ||
|2-4 | |2-4 | ||
|- | |- | ||
− | |Liver | + | |align="left" | Liver |
|0 | |0 | ||
|1 | |1 | ||
Line 60: | Line 60: | ||
The severity is the highest level which the patient reaches based on separate skin, liver, and GI staging. | The severity is the highest level which the patient reaches based on separate skin, liver, and GI staging. | ||
− | {| border="1" | + | {| border="1" style="text-align:center;" |
− | !Overall grade | + | !align="left" | Overall grade |
!A | !A | ||
!B | !B | ||
Line 67: | Line 67: | ||
!D | !D | ||
|- | |- | ||
− | |Skin | + | |align="left" | Skin |
|1 | |1 | ||
|2 | |2 | ||
Line 73: | Line 73: | ||
|4 | |4 | ||
|- | |- | ||
− | |GI | + | |align="left" | GI |
|0 | |0 | ||
|1-2 | |1-2 | ||
Line 79: | Line 79: | ||
|4 | |4 | ||
|- | |- | ||
− | |Liver | + | |align="left" | Liver |
|0 | |0 | ||
|1-2 | |1-2 |
Revision as of 07:40, 10 December 2011
Glucksberg acute graft versus host (GVHD) scores
Skin
- Stage 0: No rash
- Stage 1: Maculopapular rash <25% of body surface area
- Stage 2: Maculopapular rash on 25-50% of body surface area
- Stage 3: Generalized erythroderma
- Stage 4: Generalized erythroderma with bullous formation and desquamation
Liver
- Stage 0: Bilirubin <2 mg/dL
- Stage 1: Bilirubin 2-3 mg/dL
- Stage 2: Bilirubin 3.01-6 mg/dL
- Stage 3: Bilirubin 6.01-15.0 mg/dL
- Stage 4: Bilirubin >15 mg/dL
GI
- Stage 0: No diarrhea, or diarrhea <500 mL/day
- Stage 1: Diarrhea 500-999 mL/day
- Stage 2: Diarrhea 1000-1499 mL/day
- Stage 3: Diarrhea >1500 mL/day
- Stage 4: Severe abdominal pain, with or without ileus
Glucksberg grade
Overall grade | I | II | III | IV |
---|---|---|---|---|
Skin | 1-2 | 1-3 | 2-3 | 2-4 |
GI | 0 | 1 | 2-3 | 2-4 |
Liver | 0 | 1 | 2-4 | 2-4 |
Karnofsky performance scale | 90-100% | 70-80% | 50-60% | 30-40% |
IBMTR severity index
The severity is the highest level which the patient reaches based on separate skin, liver, and GI staging.
Overall grade | A | B | C | D |
---|---|---|---|---|
Skin | 1 | 2 | 3 | 4 |
GI | 0 | 1-2 | 3 | 4 |
Liver | 0 | 1-2 | 3 | 4 |
Chronic GVHD
Localized
- Localized skin and/or liver dysfunction due to chronic GVHD
Extensive
- Generalized skin involvement or localized skin and/or liver dysfunction due to chronic GVHD plus at least one of the following:
- Liver biopsy showing cirrhosis, chronic aggressive hepatitis, bridging necrosis
- Eye involvement, defined as Schirmer's test with <5 mm wetting
- Involvement of oral mucosa on lip biopsy or minor salivary glands
- Other organ involvement
- Overall severity categories: mild/moderate/severe
References
- Thomas E, Storb R, Clift RA, Fefer A, Johnson FL, Neiman PE, Lerner KG, Glucksberg H, Buckner CD. Bone-marrow transplantation (first of two parts). N Engl J Med. 1975 Apr 17;292(16):832-43 link to original article PubMed
- Thomas ED, Storb R, Clift RA, Fefer A, Johnson L, Neiman PE, Lerner KG, Glucksberg H, Buckner CD. Bone-marrow transplantation (second of two parts). N Engl J Med. 1975 Apr 24;292(17):895-902 link to original article (contains staging scale) PubMed
- Rowlings PA, Przepiorka D, Klein JP, Gale RP, Passweg JR, Henslee-Downey PJ, Cahn JY, Calderwood S, Gratwohl A, Socié G, Abecasis MM, Sobocinski KA, Zhang MJ, Horowitz MM. IBMTR Severity Index for grading acute graft-versus-host disease: retrospective comparison with Glucksberg grade. Br J Haematol. 1997 Jun;97(4):855-64. link to original article PubMed